CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...

According to CMS data, Medicare Part D spending ... of Medicare negotiations yielded discounts on drugs ranging from 40 percent to 80 percent, including 76 percent off the list price for NovoLog.

The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process of negotiating prices for certain Medicare Part D drugs with input ...

Rigorous answers about the program’s effects on drug innovation are still a ways off. However, some information about ...

Mehmet Oz recently took the reins as the new head of the Centers for Medicare & Medicaid Services (CMS), which oversees health coverage for nearly half of Americans. He will ...

In 2022, the U.S. Congress passed the Inflation Reduction Act, which gave Medicare the authority to negotiate certain prescription drug prices ... D. In August 2023, the Centers for Medicare and ...

In the shadow of President Trump's efforts to lower drug prices, the Medicare drug price negotiation process that began in ...

CMS said it will announce maximum fair ... Human Services on the selection of 15 additional drugs under Medicare Part D for price negotiations. We are increasingly concerned about the impact ...

Soon, the Centers for Medicare and Medicaid Services will begin the price negotiation process on a new ... some of which (like R&D costs) have nothing to do with value while others (like clinical ...